> Anokion acquired Kanyos Bio and completed a $40 million series B financing. The acquisition gives Anokion ownership of a preclinical antigen-specific treatment for celiac disease. Statement
> Genfit named Carol Addy as chief medical officer. Addy previously worked at Merck. Release
> MaaT Pharma hired Emmanuel Prestat as computational biology manager. Prestat used to work at diagnostic business HalioDx. Statement
> Ermium Therapeutics raised a €6.3 million series A round. The French biotech will use money to fund early-stage autoimmune research. Release
> Kiadis Pharma confirmed it is still on track to bring ATIR101 to market in Europe next year. Statement